Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1010153

	registered interest
	date	19/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Eating Disorders
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 16 October 2018 to Question 177617 on Eating disorders, if he will list the 70 new or extended community services providing specialist community-based care for eating disorders that are open or in development by the local authority in which they are based.
	tabling member constituency	Newcastle-under-Lyme
	tabling member printed	Paul Farrelly
	uin	192754
	answer	answer is ministerial correction date of answer 22/11/2018 answer text <p>This information is not available by local authority.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 22/11/2018 17:42:15 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	1436 label Biography information for Paul Farrelly

1016320

	registered interest
	date	28/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medicines and Healthcare products Regulatory Agency
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the transition period set out in the agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union, whether the Medicines and Healthcare Products Regulatory Agency will retain its status as a competent authority; and whether existing CE marks assigned under that agency will be valid from 29 March 2019 until the end of that transition period.
	tabling member constituency	Newcastle-under-Lyme
	tabling member printed	Paul Farrelly
	uin	196736
	answer	answer is ministerial correction date of answer 03/12/2018 answer text <p>The agreement of an implementation period will ensure that access to medicines and medical devices continues, and patient safety is maintained, in both the United Kingdom and European Union markets.</p><p> </p><p>The Medicines and Healthcare products Regulatory Agency (MHRA) will continue to be the UK competent authority during this period.</p><p> </p><p>For medical devices, CE marks are assigned by notified bodies (rather than competent authorities such as the MHRA), and during the implementation period UK notified bodies will continue to conduct third-party conformity assessment in the UK, and the results of these tests will continue to be used and recognised for both the UK and EU markets.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 03/12/2018 18:29:34 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	1436 label Biography information for Paul Farrelly

1020404

	registered interest
	date	05/12/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medicines and Healthcare products Regulatory Agency
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 03 December 2018 to Question 196736 on Medicines and Healthcare Products Regulatory Agency (MHRA), and with reference to the transition period set out in the Agreement on the Withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union, if the MHRA will be recognised as an EU competent authority under the EU (a) Medical Devices Directive, (b) in-vitro diagnostic medical devices, and (c) Medical Devices Regulation during the period covered by the Agreement.
	tabling member constituency	Newcastle-under-Lyme
	tabling member printed	Paul Farrelly
	uin	199325
	answer	answer is ministerial correction date of answer 10/12/2018 answer text <p>The agreement of an implementation period will mean that the Medicines and Healthcare products Regulatory Agency (MHRA) will continue to be recognised as a European Union competent authority designated under the EU Directives for medical devices, in vitro diagnostic medical devices and active implantable medical devices, during this period.</p><p> </p><p>This is also the case for the new EU Regulations for medical devices and in vitro diagnostic medical devices, which both entered into force in May 2017.</p><p> </p><p>It is possible for a single organisation to have individual notified bodies designated in more than one Member State. The authority within each Member State is responsible for notified bodies based in its own country.</p><p> </p><p>The MHRA is responsible for the designation and monitoring of notified bodies in the United Kingdom, which the response to Question 196736 refers to.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 199327 question first answered 10/12/2018 14:12:25 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	1436 label Biography information for Paul Farrelly

1020408

	registered interest
	date	05/12/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medical Equipment: UK Notified Bodies
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 03 December 2018 to Question 196736 on Medicines and Healthcare Products Regulatory Agency (MHRA), whether the Department's response refers to (a) UK notified bodies licensed by the MHRA and (b) UK notified bodies that have also secured notified body status in other EU states.
	tabling member constituency	Newcastle-under-Lyme
	tabling member printed	Paul Farrelly
	uin	199327
	answer	answer is ministerial correction date of answer 10/12/2018 answer text <p>The agreement of an implementation period will mean that the Medicines and Healthcare products Regulatory Agency (MHRA) will continue to be recognised as a European Union competent authority designated under the EU Directives for medical devices, in vitro diagnostic medical devices and active implantable medical devices, during this period.</p><p> </p><p>This is also the case for the new EU Regulations for medical devices and in vitro diagnostic medical devices, which both entered into force in May 2017.</p><p> </p><p>It is possible for a single organisation to have individual notified bodies designated in more than one Member State. The authority within each Member State is responsible for notified bodies based in its own country.</p><p> </p><p>The MHRA is responsible for the designation and monitoring of notified bodies in the United Kingdom, which the response to Question 196736 refers to.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 199325 question first answered 10/12/2018 14:12:25 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	1436 label Biography information for Paul Farrelly

1024789

	registered interest
	date	13/12/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Ovarian Cancer: Staffordshire
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to (a) increase early diagnosis rates for ovarian cancer and (b) increase access to treatment for ovarian cancer in specialist centres in Staffordshire.
	tabling member constituency	Newcastle-under-Lyme
	tabling member printed	Paul Farrelly
	uin	202081
	answer	answer is ministerial correction date of answer 18/12/2018 answer text <p>Public Health England (PHE) has run a number of ‘Be Clear on Cancer’ campaigns to help improve early detection of cancer including ovarian cancer. In 2014 PHE ran a pilot regional ovarian cancer campaign in the North West of England. In 2017, PHE ran a pilot campaign in the East and West Midlands which focussed on a range of abdominal symptoms, such as diarrhoea, bloating and discomfort that can be indicative of a number of cancers, including ovarian cancer. NHS England has invested over £200 million between 2017 and 2019, supporting Cancer Alliances to accelerate diagnosis and enhance quality of life.</p><p> </p><p>Staffordshire clinical commissioning groups commission diagnostic services for ovarian cancer fully in line with National Institute for Health and Care Excellence guidelines across the whole sustainability and transformation partnership.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/12/2018 17:04:54 answering member 4067 label Biography information for Steve Brine
	tabling member	1436 label Biography information for Paul Farrelly

1039590

	registered interest
	date	11/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Training
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to involve people with learning disabilities and autism in the development of mandatory training for NHS staff.
	tabling member constituency	Newcastle-under-Lyme
	tabling member printed	Paul Farrelly
	uin	207559
	answer	answer is ministerial correction date of answer 16/01/2019 answer text <p>We will shortly consult on proposals for mandatory learning disability and autism training to ensure that staff working in health and social care understand the needs of people with learning disabilities and autism and have the skills to provide them with the most effective care and support. Officials have worked with people with lived experience of learning disabilities and autism to develop the consultation proposals.</p><p> </p><p>We want to hear a range of views, including those from people with a learning disability or autism and their families, and in line with Cabinet Office principles on consultation, we will tailor the consultation to meet the needs and preferences of different groups, including the provision of consultation documents in alternative formats.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 16/01/2019 12:21:26 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	1436 label Biography information for Paul Farrelly

1043054

	registered interest
	date	17/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Finance
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to his oral contribution of 7 January 2019, Official Report column 80, when he plans to publish the local provision funding increases for the first year of the NHS Long Term Plan.
	tabling member constituency	Newcastle-under-Lyme
	tabling member printed	Paul Farrelly
	uin	209758
	answer	answer is ministerial correction date of answer 22/01/2019 answer text <p>NHS England set clinical commissioning group (CCG) allocations. The National Health Service published draft five-year CCG allocations for 2019/20 to 2023/24 on 10 January 2019 at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/publication/draft-ccg-allocations-2019-20-to-2023-24-core-services/" target="_blank">https://www.england.nhs.uk/publication/draft-ccg-allocations-2019-20-to-2023-24-core-services/</a></p><p> </p><p>These are subject to final approval by the NHS England Board on 31 January 2019.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 22/01/2019 17:04:07 answering member 1585 label Biography information for Stephen Hammond
	tabling member	1436 label Biography information for Paul Farrelly

1046830

	registered interest
	date	23/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Lung Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to (a) detect and diagnose lung disease earlier and (b) support people with chronic respiratory conditions to manage their health.
	tabling member constituency	Newcastle-under-Lyme
	tabling member printed	Paul Farrelly
	uin	211682
	answer	answer is ministerial correction date of answer 28/01/2019 answer text <p>The Government is committed to improving the lives of those with respiratory disease.</p><p>Respiratory disease is a clinical priority within the recently published NHS Long Term Plan. This has the overarching objective of improving outcomes for people with respiratory disease. The Long Term Plan sets out how the National Health Service will take action in a number of areas. This includes expanding programmes that support earlier diagnosis of respiratory disease including the pioneering lung health checks trialled in Manchester and Liverpool; increasing access to proven treatments such as pulmonary rehabilitation (a structured exercise and education programme for those with chronic respiratory disease and breathlessness); and improving support for those with chronic respiratory diseases such as asthma to receive and use the correct medications.</p><p>The NHS Long Term Plan will build on a range of existing national initiatives focussed on the diagnosis and treatment of respiratory disease, some of which are detailed below.</p><p>The NHS Outcomes Framework sets out the Department’s priority areas for the NHS, and includes reducing deaths from respiratory disease as a key indicator.</p><p>The National Institute for Health and Care Excellence (NICE) publishes quality standards that define best practice and areas in need of improvement for a range of respiratory illnesses including chronic obstructive pulmonary disease (COPD), asthma and idiopathic pulmonary fibrosis, with the aim of raising the standard of care that people with these conditions receive. NICE quality standards cover both diagnosis and treatment.</p><p>The NHS RightCare COPD pathway is being rolled out nationally through clinical commissioning groups and defines the core components of an optimal service for people with COPD. This includes timely access to pulmonary rehabilitation as part of the optimal treatment pathway.</p><p>The Department and NHS England are supportive of the National Asthma and COPD Audit Programme. Launched in March 2018 and led by the Royal College of Physicians, this programme aims to improve quality of care, services, and clinical outcomes for patients with asthma and COPD by collecting and providing data on a range of indicators.</p><p>Furthermore, NHS England commissions treatments for rare or complex respiratory conditions through the Specialised Respiratory Clinical Reference Group, which is chaired by Professor Mike Morgan. This includes specialist treatment for pulmonary hypertension, idiopathic pulmonary fibrosis and severe asthma among other conditions.</p><p>The Department also funds research on respiratory illnesses through the National Institute for Health Research.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 28/01/2019 17:16:04 answering member 4067 label Biography information for Steve Brine
	tabling member	1436 label Biography information for Paul Farrelly

1046835

	registered interest
	date	23/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Lung Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how much funding will be allocated to the respiratory programme set out in the NHS Long Term Plan.
	tabling member constituency	Newcastle-under-Lyme
	tabling member printed	Paul Farrelly
	uin	211683
	answer	answer is ministerial correction date of answer 28/01/2019 answer text <p>NHS England is not able to release exact figures at present.</p><p>The National Implementation Framework, to be published in the spring, will provide further information on how the Long Term Plan will be implemented. Further details, based on local health system five year plans, will be brought together in a detailed national implementation plan in the autumn.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 28/01/2019 17:14:13 answering member 4067 label Biography information for Steve Brine
	tabling member	1436 label Biography information for Paul Farrelly

1057001

	registered interest
	date	08/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Reciprocal Arrangements
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that British citizens can access medical treatment in EU countries (a) for free or (b) at a reduced cost after 29 March 2019.
	tabling member constituency	Newcastle-under-Lyme
	tabling member printed	Paul Farrelly
	uin	218765
	answer	answer is ministerial correction date of answer 15/02/2019 answer text <p>The United Kingdom Government appreciates the importance of retaining reciprocal healthcare arrangements with the European Union and has been clear in the negotiations that it wants to protect the rights of UK citizens in the EU.</p><p>Subject to the Withdrawal Agreement being agreed by Parliament, during the implementation period the current rules on reciprocal healthcare will continue until December 2020. The rights of UK nationals living in the EU, and who fall within the scope of the Withdrawal Agreement, will continue to be protected after December 2020, for as long as these individuals remain in scope of the Withdrawal Agreement.</p><p>In the event that the UK exits the EU without a deal, EU citizens resident in the UK by 29 March 2019 will be able to stay and continue to access in country benefits and services, including healthcare, on broadly the same terms as now. This demonstrates the UK Government’s ongoing commitment to citizens and removes any ambiguity over their future. We are engaging with EU counterparts to urge them to make the same commitment to protect the rights of UK nationals in the EU. The UK Government is seeking agreements with Member States, so that no individual will face sudden changes to their healthcare cover.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 15/02/2019 11:07:37 answering member 1585 label Biography information for Stephen Hammond
	tabling member	1436 label Biography information for Paul Farrelly